NEW YORK–(BUSINESS WIRE)–A new survey of more than 250 alternative investment professionals finds that a strong majority expect a return to pre-pandemic levels of deal activity by the close of 2021. The survey, conducted during EisnerAmper’s Virtual 5th Annual Alternative Investment Summit, shows that 74% of industry professionals predict a return to pre-COVID-19 deal activity…
DetailsCHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the launch of its Remedi brand and its Renew and Realign spray tinctures and Renew capsules in New York. In addition, Cresco has received approval for both THC only and 1:1…
DetailsTORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce that Umar Syed has been appointed President, U.S. & International medical products for Heritage. Mr. Syed was the CEO of Opticann Inc., a company acquired by Heritage in early October 2020. Previously, he was Senior Vice President of…
DetailsDUBLIN–(BUSINESS WIRE)–The “CBD Oil & CBD Consumer Health Market Size, Share & Trends Analysis Report by Product, by Distribution Channel, by Region (North America, Europe, Asia Pacific, Latin America, MEA), and Segment Forecasts, 2020 – 2027” report has been added to ResearchAndMarkets.com’s offering. The global CBD oil and CBD consumer health market size is expected…
DetailsLONDON–(BUSINESS WIRE)–The CBD cosmetics market size is poised to grow by USD 3.09 billion during 2020-2024, progressing at a CAGR of about 31% throughout the forecast period, according to the latest report by Technavio. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. The…
DetailsCRANBURY, N.J.–(BUSINESS WIRE)–Physicians’ Education Resource® LLC (PER®), in partnership with Psychiatric Times®, is pleased to present the Annual Psychiatric Times® World CME Conference™ as a three-day continuing medical education (CME)-certified, virtual, interactive event Oct. 15-17. “The Psychiatric Times® World CME Conference™ will bring together top psychiatric experts to discuss many of the pressing topics in…
Details
Also known as cannabidiol, CBD oil is a natural remedy that’s quickly growing in popularity, and for good reason. Extracted from the marijuana plant, CBD oil doesn’t contain THC, which is the psychoactive property of the plant. Thinking about trying it for yourself? A reputable dealer, such as Buy It CBD, is a great place…
DetailsDUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Review, H2 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Epilepsy – Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Epilepsy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.…
DetailsNEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the third quarter ended September 30, 2020 after close of US financial markets on Thursday, November 12, 2020. Following the release of financial results, Company management will…
DetailsLOS ANGELES–(BUSINESS WIRE)–Inception REIT (“I-REIT”) announced it has entered into a merger agreement with Subversive Real Estate Acquisition REIT LP (NEO: SVX.U) (NEO: SVX.RT.U) (OTCBB: SBVRF) (“Subversive REIT”). The transaction includes two properties, one retail and one industrial, and one retail mortgage across Southern California in downtown Los Angeles, Desert Hot Springs and Coachella, with…
DetailsTORONTO–(BUSINESS WIRE)–Bluma Wellness Inc. (the “Company” or “Bluma Wellness”) (CSE:BWEL.U) is pleased to announce that its wholly-owned operating subsidiary, One Plant Florida, intends to open its sixth retail dispensary and delivery hub, located in Avon Park, Florida on or before Monday, October 19, 2020, subject to the receipt of all required regulatory approvals from the…
DetailsCAMBRIDGE, Mass.–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced that it will present clinical data from a Phase 1 study of its lead precision kidney therapeutic candidate, GFB-887, at the American Society of Nephrology (ASN) Kidney Week 2020 Annual Meeting,…
Details